Saluja A - Search Results

1

Inhibition of epithelial ovarian cancer by Minnelide, a water-soluble pro-drug.

Rivard C, Geller M, Schnettler E, Saluja M, Vogel RI, Saluja A, Ramakrishnan S. Rivard C, et al. Among authors: saluja m, saluja a. Gynecol Oncol. 2014 Nov;135(2):318-24. doi: 10.1016/j.ygyno.2014.08.031. Epub 2014 Aug 27. Gynecol Oncol. 2014. PMID: 25172764 Free PMC article.

2

Impaired Synthesis of Stromal Components in Response to Minnelide Improves Vascular Function, Drug Delivery, and Survival in Pancreatic Cancer.

Banerjee S, Modi S, McGinn O, Zhao X, Dudeja V, Ramakrishnan S, Saluja AK. Banerjee S, et al. Clin Cancer Res. 2016 Jan 15;22(2):415-25. doi: 10.1158/1078-0432.CCR-15-1155. Epub 2015 Sep 24. Clin Cancer Res. 2016. PMID: 26405195 Free PMC article.

3

A Novel Immunocompetent Mouse Model of Pancreatic Cancer with Robust Stroma: a Valuable Tool for Preclinical Evaluation of New Therapies.

Majumder K, Arora N, Modi S, Chugh R, Nomura A, Giri B, Dawra R, Ramakrishnan S, Banerjee S, Saluja A, Dudeja V. Majumder K, et al. Among authors: saluja a. J Gastrointest Surg. 2016 Jan;20(1):53-65; discussion 65. doi: 10.1007/s11605-015-2985-y. Epub 2015 Nov 18. J Gastrointest Surg. 2016. PMID: 26582596 Free PMC article.

4

Wild-type p53 reactivation by small-molecule Minnelide™ in human papillomavirus (HPV)-positive head and neck squamous cell carcinoma.

Caicedo-Granados E, Lin R, Fujisawa C, Yueh B, Sangwan V, Saluja A. Caicedo-Granados E, et al. Among authors: saluja a. Oral Oncol. 2014 Dec;50(12):1149-56. doi: 10.1016/j.oraloncology.2014.09.013. Epub 2014 Oct 11. Oral Oncol. 2014. PMID: 25311433 Free PMC article.

5

Minnelide, a novel drug for pancreatic and liver cancer.

Banerjee S, Saluja A. Banerjee S, et al. Among authors: saluja a. Pancreatology. 2015 Jul;15(4 Suppl):S39-43. doi: 10.1016/j.pan.2015.05.472. Epub 2015 Jun 18. Pancreatology. 2015. PMID: 26122306 Free PMC article. Review.

6

Minnelide, a prodrug, inhibits cervical cancer growth by blocking HPV-induced changes in p53 and pRb.

Ramakrishnan V, de Haydu C, Wilkinson P, Hooda U, Giri B, Oleas JM, Rive V, Roy S, Dudeja V, Slomovitch B, Saluja A, Ramakrishnan S. Ramakrishnan V, et al. Among authors: saluja a. Am J Cancer Res. 2021 May 15;11(5):2202-2214. eCollection 2021. Am J Cancer Res. 2021. PMID: 34094678 Free PMC article.

7

A preclinical evaluation of Minnelide as a therapeutic agent against pancreatic cancer.

Chugh R, Sangwan V, Patil SP, Dudeja V, Dawra RK, Banerjee S, Schumacher RJ, Blazar BR, Georg GI, Vickers SM, Saluja AK. Chugh R, et al. Sci Transl Med. 2012 Oct 17;4(156):156ra139. doi: 10.1126/scitranslmed.3004334. Sci Transl Med. 2012. PMID: 23076356 Free PMC article.

8

Minnelide effectively eliminates CD133(+) side population in pancreatic cancer.

Nomura A, McGinn O, Dudeja V, Sangwan V, Saluja AK, Banerjee S. Nomura A, et al. Among authors: saluja ak. Mol Cancer. 2015 Nov 23;14:200. doi: 10.1186/s12943-015-0470-6. Mol Cancer. 2015. PMID: 26597727 Free PMC article.

9

CD133+ tumor initiating cells in a syngenic murine model of pancreatic cancer respond to Minnelide.

Banerjee S, Nomura A, Sangwan V, Chugh R, Dudeja V, Vickers SM, Saluja A. Banerjee S, et al. Among authors: saluja a. Clin Cancer Res. 2014 May 1;20(9):2388-99. doi: 10.1158/1078-0432.CCR-13-2947. Epub 2014 Mar 14. Clin Cancer Res. 2014. PMID: 24634377 Free PMC article.

10

Minnelide reduces tumor burden in preclinical models of osteosarcoma.

Banerjee S, Thayanithy V, Sangwan V, Mackenzie TN, Saluja AK, Subramanian S. Banerjee S, et al. Cancer Lett. 2013 Jul 28;335(2):412-20. doi: 10.1016/j.canlet.2013.02.050. Epub 2013 Mar 14. Cancer Lett. 2013. PMID: 23499892 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

306 results

Search Page

Filters